Advertisement
Atherosclerosis
Advanced SearchSave search
Full length article| Volume 9, ISSUE 3, P251-265, May 06, 1969

The pediatric aspects of atherosclerosis

DOI:https://doi.org/10.1016/S0368-1319(69)80020-7
The pediatric aspects of atherosclerosis
Previous ArticlePattern of vessel involvement in cerebral atherosclerosis
Next ArticleExacerbation of spontaneously occurring arteriosclerosis in breeder rats following chronic treatment with cortisone
      This paper is only available as a PDF. To read, Please Download here.

      Summary

      Atherosclerosis begins in childhood with the appearance of aortic fatty streaks. Aortic fatty streaks of some degree are present in practically all individuals from every human population that has been studied. The average amount of aortic intimai surface involved with fatty streaks does not differ much among human populations.
      Coronary fatty streaks begin to form in adolescence. Most persons 20-29 years of age have coronary fatty streaks of some degree, even if they are from low socioeconomic strata.
      While fatty streaking is clinically harmless and potentially reversible, the progression of fatty streaks to more advanced lesions is a critical stage of atherosclerosis. This conversion takes place at earlier ages in populations with high morbidity and mortality from coronary heart disease.
      The development of fibrous plaques begins in the twenties. Therefore, even though control programs which attempt to reduce coronary heart disease by preventing atherosclerosis may meet some success when applied to middle-aged persons, these programs should be directed toward individuals in the twenties and thirties for maximum benefits. Dietary habits that retard atherosclerosis should be established in childhood.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Holman R.L.
        Atherosclerosis — A pediatric nutrition problem?.
        Amer. J. clin. Nutr. 1961; 9: 565
        • Klotz O.
        • Manning M.F.
        Fatty streaks in the intima of arteries.
        J. Path. Bad. 1911; 16: 211
        • Zinserling W.D.
        Untersuchungen über Atherosklerose, Teil 1 (Über die Aortaverfettung bei Kindern).
        Vichows Arch. path. Anat. 1925; 255: 677
        • Zeek P.
        Juvenile arteriosclerosis.
        Arch. Path. 1930; 10: 417
        • Albert Z.
        Die Veränderungen der Aorta bei Kindern und ihr Verhältnis zur Atherosklerose.
        Virchows Arch. path. Anat. 1939; 303: 265
        • Holman R.L.
        • McGill Jr., H.C.
        • Strong J.P.
        • Geer J.C.
        The natural history of atherosclerosis: The early aortic lesions as seen in New Orleans in the middle of the 20th century.
        Amer. J. Path. 1968; 34: 209
        • Strong J.P.
        • McGill Jr., H.C.
        The natural history of aortic atherosclerosis: relationship to race, sex, and coronary lesions in New Orleans.
        Exp. mol. Path. 1963; : 15
        • Strong J.P.
        • McGill Jr., H.C.
        The natural history of coronary atherosclerosis.
        Amer. J. Path. 1962; 40: 37
        • Strong J.P.
        • McGill Jr., H.C.
        • Tejada C.
        • Holman R.L.
        The natural history of atherosclerosis: comparison of early aortic lesions in New Orleans, Guatemala, and Costa Rica.
        Amer. J. Path. 1958; 34: 731
        • Restrepo C.
        • McGill Jr., H.C.
        The early lesions of aortic atherosclerosis in Cali, Colombia.
        Arch. Path. 1959; 67: 618
        • Strong J.P.
        • Wainvvright J.
        • McGill Jr., H.C.
        Atherosclerosis in the Bantu.
        Circulation. 1959; 20: 118
        • Galindo L.
        • Arean V.
        • Strong J.P.
        • Baldizon C.
        Atherosclerosis in Puerto Rico.
        Arch. Path. 1961; 72: 367
        • McGill Jr., H.C.
        The geographic pathology of atheroclerosis.
        Lab. Invest. 1968; 18: 463
        • Tejada C.
        • Strong J.P.
        • Montenegro M.R.
        • Restrepo C.
        • Solberg L.A.
        Distribution of coronary and aortic atherosclerosis by geographic location, race and sex.
        Lab. Invest. 1968; 18: 49
        • McMahan C.A.
        Autopsied cases by age, sex and “race”.
        Lab. Invest. 1968; 18: 8
        • Guzmán M.A.
        • McMahan C.A.
        • McGill Jr., H.C.
        • Strong J.P.
        • Tejada C.
        • Restrepo C.
        • Eggen D.A.
        • Robertson W.B.
        • Solberg L.A.
        Selected méthodologic aspects of the international atherosclerosis project.
        Lab. Invest. 1968; 18: 19
        • Geer J.C
        • McGill Jr., H.C.
        • Robertson W.B.
        • Strong J.P.
        Histologic characteristics of coronary artery fatty streaks.
        Lab. Invest. 1968; 18: 105
        • McGill Jr., H.C.
        Fatty streaks in the coronary arteries and aorta.
        Lab. Invest. 1968; 18: 100
        • Montenegro M.R.
        • Eggen D.A.
        Topography of atherosclerosis in the coronary arteries.
        Lab. Invest. 1968; 18: 126

      Article Info

      Publication History

      Received: October 24, 1968

      Identification

      DOI: https://doi.org/10.1016/S0368-1319(69)80020-7

      Copyright

      © 1969 Elsevier Publishing Company, Amsterdam. Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX